Download in electronic PDF format for $35



Search the Complete Journal Archives

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia

Author(s):  Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa

Issue:  May/Jun 2018 - Volume 22, Number 3
View All Articles in Issue

Abstract:  Fibromyalgia is a syndrome associated with chronic, widespread musculoskeletal pain, fatigue, depression, and cognitive dysfunction. With few U.S. Food and Drug Administration-approved treatment options, there is evidence that low-dose naltrexone, an opioid antagonist approved for opioid and alcohol dependence at high doses, may have efficacy in the treatment of fibromyalgia and chronic pain. At the doses required for fibromyalgia treatment, naltrexone needs to be compounded, and no data currently exists regarding the long-term stability of low-dose naltrexone capsules. This limits pharmacies to a maximum beyond-use date of 180 days. Our study examined the stability of compounded capsules of low-dose naltrexone in Avicel over 360 days. Naltrexone was extracted from compounded capsules and assessed using reversed-phase high-performance liquid chromatography validated to differentiate between the degraded and undegraded naltrexone. United States Pharmacopeia guidelines state that compounded medications must remain within 10% of the labeled potency at all times during the assigned expiration date for a preparation. Our results show that low-dose naltrexone is stable for 360 days when stored at room temperature and away from light remaining within 90% to 110% of the labeled potency throughout the study period. Based on our study results, the beyond-use date for compounded low-dose naltrexone formulations stored at room temperature and protected from light can be extended to 1 year. The longer beyond-use dating allows patients greater flexibility in using these capsules during the flare-ups associated with fibromyalgia without needing a refill immediately at the onset of symptoms. In addition, it may help compounding pharmacies reduce waste associated with small-batch preparation of these capsules.

Related Keywords: Brianna Cote, PharmD, Bethany Ross, BS, Jeff Fortner, PharmD, Deepa Rao, PhD, naltrexone, fibromyalgia, chronic musculoskeletal pain, competitive opioid antagonist, chemical stability

Related Categories: MENTAL HEALTH, PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa May/Jun 2018 252-256 Buy
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa Sep/Oct 2015 414-419 Buy
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches Burrows Anna C, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L Jul/Aug 2019 340-350 Buy
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Sturn Kayla M, Collin Michael May/Jun 2016 197-201 Buy
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi Jul/Aug 2015 295-300 Buy
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L May/Jun 2010 193-199 Buy
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A Mar/Apr 2019 157-162 Buy
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap Jan/Feb 2019 62-64 Buy
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Jones Marty Jan/Feb 2002 4-6 Buy
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine Jul/Aug 2017 347-351 Buy